Anti-small molecule hapten antibodies

Anti-small molecule hapten antibodies · 09. June 2022

TACA, promising oncology targets?

SYnAbs develops therapeutic IgG antibodies highly specific to carbohydrates by combining unique technologies and expertise to break immune tolerance in rat-LOU and transgenic animal species

Anti-small molecule hapten antibodies · 28. November 2020

Bald & Bearded : the DHT effect

SYnAbs unique anti-dihydrotestosterone (anti-DHT) monoclonal antibodies of a pg sensitivity level and no cross-reactivity to free testosterone

Anti-small molecule hapten antibodies · 17. October 2020

Glycan & anti-glycan : the rise of glycobiology

Combining the appropriate antigen synthesis, the design of particular carrier linked at the perfect attachment site, its proprietary adjuvant and the access to plasmocytes of lymph nodes and bone marrow, SYnabs has developed an expertise in the generation of high affinity IgG monoclonal antibodies against glycans.

Anti-small molecule hapten antibodies · 16. January 2020

In accordance with FDA, can a biotinylated mAb be replaced by a DNP marked mAb?

DNP is an excellent alternative to biotin for use in applications requiring biotin-free systems. Probes or antibodies labeled with DNP can be detected using the SYnAbs anti-DNP monoclonal antibodies.

Anti-small molecule hapten antibodies · 14. November 2019

Mycotoxins: the reign of terror

SYnAbs developed high sensitive anti-mycotoxins monoclonal antibodies for ELISA, lateral flow and preparative immuno-affinity columns applications.

Anti-small molecule hapten antibodies · 25. September 2019

Understanding DNP and Its Applications in Research: The Role of Monoclonal Antibodies

SYnAbs unique anti-DNP monoclonal antibodies of higher performance. DNP is a small molecule detected by innovative SYnAbs monoclonals and that replaces biotin-streptavidin detection mode.

Anti-small molecule hapten antibodies · 11. March 2019

Neurogenic and SYnAbs deal for schizophrenia detection

SYnAbs generates custom monoclonal antibodies against small synthetic peptides to early diagnose schizophrenia mental disorder

Anti-small molecule hapten antibodies · 28. January 2019

Horiba & SYnAbs partnership : Production of monoclonal antibody directed against a steroid hormone and its binding study thanks to SPRi technology

Production of guinea pig monoclonal antibody directed against a steroid hormone and its binding study thanks to Surface Plasmon Resonance imaging technology

Anti-small molecule hapten antibodies · 03. August 2016

The small molecule detection challenge : the aflatoxin case study

Custom generation of higher affinity rat monoclonal antibodies against aflatoxins